Acupressure and anxiety in women with gestational diabetes

Authors
Category Primary study
Registry of TrialsIranian Registry of Clinical Trials
Year 2012
INTERVENTION: Intervention 1: The intervention in the experimental group was acupressure at the point of P7 for five minutes on each side of the body, three times a day for four consecutive days. Intervention 2: The intervention on the control or placebo group was touching instead of acupressure at the point of P7 for five minutes on each side of the body, three times a day for four consecutive days. The intervention in the experimental group was acupressure at the point of P7 for five minutes on each side of the body, three times a day for four consecutive days. The intervention on the control or placebo group was touching instead of acupressure at the point of P7 for five minutes on each side of the body, three times a day for four consecutive days. CONDITION: Anxiety‐Post‐traumatic stress disorder. ; F43.0 (Post‐traumatic stress disorder) and F41.1 (Generalized anxiety disorder) F43.0 (Post‐traumatic stress disorder) and F41.1 (Generalized anxiety disorder) F43.0, F41 PRIMARY OUTCOME: Anxiety and its severity. Timepoint: at pre‐test (before the intervention) and post‐test (at the end of the fourth day of the intervention). Method of measurement: a questionnaire of maternal anxiety and the Visual analogue scale (VAS). INCLUSION CRITERIA: INCLUSION CRITERIA: All women aged between 15 and 42 years old, who attended and hospitalized in the Akbarabadi Hospital, the High Risk Obstetrical Unit between August 23, 2011, and October 23, 2011, for treatment of gestational diabetes, who mentioned the feeling of anxiety and no previous experience of acupressure, and signed the written informed consent. Exclusion criteria: not participating in the trial for any reason, and the subjects in the experimental group who did not feel the heavy and numbness feelings during the intervention (acupressure) at the selective point.
Epistemonikos ID: 00c8df1f4e022fdb794ba007fe79fa6405b10ca1
First added on: Aug 22, 2024